May 24, 2013 at 18:05 PM EDT
Valeant May Buy Bausch & Lomb
The Wall Street Journal reported that Valeant Pharmaceuticals International Inc. (NYSE: VRX) was close to finalizing a deal to acquire Bausch & Lomb for approximately $9 billion sending the stock price soaring $9.80 to close at $84.47.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here